DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder

Laboratory Investigation

Volumn 80, Issue 10, 2000, Pages 1513-1522

  Florl, Andrea R ^a   Franke, Knut H ^a   Niederacher, Dieter ^a   Gerharz, Claus Dieter ^a   Seifert, Hans Helge ^a   Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ALLELE; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER STAGING; CELL CYCLE; CHROMOSOME 9P; DNA METHYLATION; GENE DELETION; GENE INACTIVATION; GENE LOCUS; GENETIC RECOMBINATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0033787302     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780161     Document Type: Article

References (39)

1. A high prevalence of functional inactivation by methylation modification of p16(INK4A)/CDKN2/MTS1 gene in primary urothelial cancers
2. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer
3. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization
4. p16 involvement in primary bladder tumors: Analysis of deletions and mutations
5. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines
6. A comparison between microsatellite and quantitative PCR analyses to detect frequent p16 copy number changes in primary bladder tumors
7. DNA hypomethylation leads to elevated mutation rates
8. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: Implication for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer
9. DNA hypomethylation and cancer
10. Accumulation of nuclear p53 and tumor progression in bladder cancer
11. DNA methylation and expression of L1 LINE and HERV-K provirus sequences in urothelial and renal cell carcinoma
12. Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
13. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines
14. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel
15. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
16. Methylation-specific PCR: A novel assay for methylation status of CpG islands
17. An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome
18. Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence
19. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma
20. Infrequent somatic mutation of the MTS1 gene in primary bladder carcinomas
21. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization
22. A cell cycle regulator potentially involved in genesis of many tumor types
23. The impact of L1 retrotransposons on the human genome
24. The genetics of transitional cell carcinoma: Progress and potential clinical application
25. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer
26. 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
27. Deletion of the p16 and p15 genes in human bladder tumors
28. Deletions of the INK4A gene in superficial bladder tumors
29. Molecular alterations in bladder cancer
30. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors
31. Molecular genetic alterations in superficial and locally advanced human bladder cancer
32. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
33. Identifying 5-methylcytosine and related modifications in DNA genomes
34. The p16INK4A/CDKN2A tumor suppressor and its relatives
35. DNA methylation in urological malignancies
36. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
37. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene
38. Overcoming cellular senescence in human cancer pathogenesis
39. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa)